Report of Foreign Issuer (6-k)

Date : 03/14/2017 @ 1:28PM
Source : Edgar (US Regulatory)
Stock : Gw Pharmaceuticals Plc. (PC) (GWPRF)
Quote : 9.3  0.04 (0.43%) @ 3:43PM

Report of Foreign Issuer (6-k)

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of March, 2017

 

Commission File Number: 001-35892

 

 

GW PHARMACEUTICALS PLC

(Translation of registrant’s name into English)

 

 

Sovereign House

Vision Park

Histon

Cambridge CB24 9BZ

United Kingdom

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   x   Form 40-F   ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes   ¨   No   ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes   ¨   No   ¨

 

 

 

 

Results of Annual Meeting of Shareholders

 

On March 14, 2017, GW Pharmaceuticals plc (the “Company”) announced that it held its annual general shareholder meeting that day and that all the resolutions set out in the notice of meeting sent to shareholders were duly proposed and passed. A summary of the results of the meeting is attached hereto as Exhibits 99.1 and is incorporated by reference herein. On March 14, 2017, the Company also updated its corporate presentation. A copy of the updated corporate presentation is attached hereto as Exhibit 99.2 and is incorporated by reference herein.

 

The information contained in Exhibit 99.1 and Exhibit 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly set forth by specific reference in such a filing.

 

Exhibits

 

99.1 Announcement of Results of Annual General Meeting

 

99.2 Updated Corporate Presentation dated March 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GW Pharmaceuticals plc
     
  By: /s/ Adam George
  Name: Adam George
  Title: Company Secretary
     
Date: March 14, 2017    

 

 

 

 

 

Gw Pharmaceuticals Plc. (PC) (USOTC:GWPRF)
Historical Stock Chart

1 Year : From Apr 2016 to Apr 2017

Click Here for more Gw Pharmaceuticals Plc. (PC) Charts.

Gw Pharmaceuticals Plc. (PC) (USOTC:GWPRF)
Intraday Stock Chart

Today : Tuesday 25 April 2017

Click Here for more Gw Pharmaceuticals Plc. (PC) Charts.



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.